VINCENZO MANGIONE: Open Payments
NPI 1326605833 · LONG ISLAND CITY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,673 in 123 payments from 20 companies in 2025. Trend: 2023 $2,843 · 2024 $2,962 · 2025 $2,673
Food & beverage: $2,673
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $483 |
| UCB, Inc. | 13 | $287 |
| GENZYME CORPORATION | 11 | $287 |
| E.R. Squibb & Sons, L.L.C. | 14 | $272 |
| Novartis Pharmaceuticals Corporation | 9 | $242 |
| Janssen Biotech, Inc. | 9 | $198 |
| Arcutis Biotherapeutics, Inc. | 8 | $139 |
| LEO Pharma Inc. | 7 | $137 |
| Regeneron Healthcare Solutions, Inc. | 5 | $122 |
| Galderma Laboratories, L.P. | 4 | $90 |
Products named: DUPIXENT, Bimzelx, RINVOQ, Sotyktu, SKYRIZI, TREMFYA, COSENTYX, Zoryve.
Industry payments across NY — which companies pay providers there.
